STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection

mBio

Volumn 4, Issue 3, 2013, Pages

  Barker, Jeffrey R ^a   Koestler, Benjamin J ^b   Carpenter, Victoria K ^a   Burdette, Dara L ^c   Waters, Christopher M ^b   Vance, Russell E ^c   Valdivia, Raphael H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Michigan State University ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLIC AMP; CYCLIC DI AMP; EXTRACHROMOSOMAL DNA; INTERFERON; UNCLASSIFIED DRUG; CYCLIC DIADENOSINE PHOSPHATE; DINUCLEOSIDE PHOSPHATE; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; MPYS PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOSOL; DIADENYLATE CYCLASE A GENE; ENDOPLASMIC RETICULUM; GENE ACTIVATION; GENE FUNCTION; GENE LOCATION; GENETIC VARIABILITY; LUNG FIBROBLAST; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STIMULATOR OF INTERFERON GENE; ANIMAL; C57BL MOUSE; CELL CULTURE; HUMAN; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS);

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; MAMMALIA; NEGIBACTERIA; POSIBACTERIA;

ANIMALS; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DINUCLEOSIDE PHOSPHATES; HUMANS; INTERFERON-BETA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL;

EID: 84878616469     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00018-13     Document Type: Article

References (74)

1. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. 2010. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis. 201:S134-S155.
2. Abdelrahman YM, Belland RJ. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29:949-959.
3. Hybiske K, Stephens RS. 2007. Mechanisms of host cell exit by the intracellular bacterium chlamydia. Proc. Natl. Acad. Sci. U. S. A. 104: 11430-11435.
4. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820.
5. Monroe KM, McWhirter SM, Vance RE. 2010. Induction of type I interferons by bacteria. Cell. Microbiol. 12:881-890.
6. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145.
7. Robinson N, McComb S, Mulligan R, Dudani R, Krishnan L, Sad S. 2012. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13: 954-962.
8. Nagarajan UM, Prantner D, Sikes JD, Andrews CW, Jr, Goodwin AM, Nagarajan S, Darville T. 2008. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76:4642-4648.
9. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200:527-533.
10. Gratz N, Hartweger H, Matt U, Kratochvill F, Janos M, Sigel S, Drobits B, Li XD, Knapp S, Kovarik P. 2011. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog. 7:e1001345. http://dx.doi.10.1371/journal.ppat.1001345.
11. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, Perry AK, Nguyen BO, Lane TF, Taniguchi T, Miller JF, Cheng G. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200:437-445.
12. Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Núñez G. 2007. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J. Immunol. 178:2380-2386.
13. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10:1065-1072.
14. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65.
15. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
16. Sun L, Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-791.
17. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678.
18. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550.
19. Sun W, Li Y, Chen L, Chen H, You F, Zhou X, Zhou Y, Zhai Z, Chen D, Jiang Z. 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. U. S. A. 106:8653-8658.
20. Jin L, Waterman PM, Jonscher KR, Short CM, Reisdorph NA, Cambier JC. 2008. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28:5014-5026.
21. Derbigny WA, Johnson RM, Toomey KS, Ofner S, Jayarapu K. 2010. The Chlamydia muridarum-induced IFN-beta response is TLR3-dependent in murine oviduct epithelial cells. J. Immunol. 185:6689-6697.
22. Prantner D, Darville T, Nagarajan UM. 2010. Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection. J. Immunol. 184:2551-2560.
23. Ishikawa H, Barber GN. 2011. The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cell. Mol. Life Sci. 68:1157-1165.
24. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515-518.
25. Holm CK, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB, Gonzalez-Dosal R, Rasmussen SB, Christensen MH, Yarovinsky TO, Rixon FJ, Herold BC, Fitzgerald KA, Paludan SR. 2012. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat. Immunol. 13:737-743.
26. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S. 2009. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 106:20842-20846.
27. Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. 2012. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11:469-480.
28. Schwartz KT, Carleton JD, Quillin SJ, Rollins SD, Portnoy DA, Leber JH. 2012. Hyperinduction of host beta interferon by a Listeria monocytogenes strain naturally overexpressing the multidrug efflux pump MdrT. Infect. Immun. 80:1537-1545.
29. Woodward JJ, Iavarone AT, Portnoy DA. 2010. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328:1703-1705.
30. Abdul-Sater AA, Grajkowski A, Erdjument-Bromage H, Plumlee C, Levi A, Schreiber MT, Lee C, Shuman H, Beaucage SL, Schindler C. 2012. The overlapping host responses to bacterial cyclic dinucleotides. Microbes Infect. 14:188-197.
31. Römling U. 2008. Great times for small molecules: c-di-AMP, a second messenger candidate in bacteria and Archaea. Sci. Signal. 1:e39. http://dx.doi.10.1126/scisignal.133pe39.
32. Tamayo R, Pratt JT, Camilli A. 2007. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61:131-148.
33. Oppenheimer-Shaanan Y, Wexselblatt E, Katzhendler J, Yavin E, Ben-Yehuda S. 2011. c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep. 12:594-601.
34. Witte G, Hartung S, Büttner K, Hopfner KP. 2008. Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol. Cell 30:167-178.
35. Corrigan RM, Abbott JC, Burhenne H, Kaever V, Gründling A. 2011. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog. 7:e1002217. http://dx.doi.10.1371/journal.ppat.1002217.
36. Luo Y, Helmann JD. 2012. Analysis of the role of Bacillus subtilis (M) in ÷-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol. Microbiol. 83:623-639.
37. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:788-792.
38. Yin Q, Tian Y, Kabaleeswaran V, Jiang X, Tu D, Eck MJ, Chen ZJ, Wu H. 2012. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol. Cell 46:735-745.
39. Nitta S, Sakamoto N, Nakagawa M, Kakinuma S, Mishima K, Kusano-Kitazume A, Kiyohashi K, Murakawa M, Nishimura-Sakurai Y, Azuma S, Tasaka-Fujita M, Asahina Y, Yoneyama M, Fujita T, Watanabe M. 2013. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type-I interferon-dependent innate immunity. Hepatology 57: 46-58.
40. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12:959-965.
41. Jin L, Hill KK, Filak H, Mogan J, Knowles H, Zhang B, Perraud AL, Cambier JC, Lenz LL. 2011. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J. Immunol. 187:2595-2601.
42. Devitt A, Lund PA, Morris AG, Pearce JH. 1996. Induction of alpha/beta interferon and dependent nitric oxide synthesis during Chlamydia trachomatis infection of McCoy cells in the absence of exogenous cytokine. Infect. Immun. 64:3951-3956.
43. Rödel J, Groh A, Vogelsang H, Lehmann M, Hartmann M, Straube E. 1998. Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. Infect. Immun. 66:4491-4495.
44. Rödel J, Vogelsang H, Prager K, Hartmann M, Schmidt KH, Straube E. 2002. Role of interferon-stimulated gene factor 3gamma and beta interferon in HLA class I enhancement in synovial fibroblasts upon infection with Chlamydia trachomatis. Infect. Immun. 70:6140-6146.
45. Lad SP, Fukuda EY, Li J, de la Maza LM, Li E. 2005. Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection. J. Immunol. 174:7186-7193.
46. Vignola MJ, Kashatus DF, Taylor GA, Counter CM, Valdivia RH. 2010. cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis. J. Biol. Chem. 285:21625-21635.
47. Derbigny WA, Hong SC, Kerr MS, Temkit M, Johnson RM. 2007. Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF. Infect. Immun. 75:1280-1290.
48. Mehne FM, Gunka K, Eilers H, Herzberg C, Kaever V, Stulke J. 2012. Cyclic di-AMP homeostasis in Bacillus subtilis: both lack and high-level accumulation of the nucleotide are detrimental for cell growth. J. Biol. Chem. 288:2004-2017
49. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL, Caldwell HD. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. U. S. A. 100:8478-8483.
50. Saka HA, Thompson JW, Chen YS, Kumar Y, Dubois LG, Moseley MA, Valdivia RH. 2011. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms. Mol. Microbiol. 82:1185-1203.
51. Sauer JD, Sotelo-Troha K, von Moltke J, Monroe KM, Rae CS, Brubaker SW, Hyodo M, Hayakawa Y, Woodward JJ, Portnoy DA, Vance RE. 2011. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79: 688-694.
52. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
53. Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-830.
54. O'Hayer KM, Counter CM. 2006. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. Methods Enzymol. 407:637-647.
55. Burdette DL, Vance RE. 2013. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14:19-26.
56. Davies BW, Bogard RW, Young TS, Mekalanos JJ. 2012. Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149:358-370.
57. Coers J, Bernstein-Hanley I, Grotsky D, Parvanova I, Howard JC, Taylor GA, Dietrich WF, Starnbach MN. 2008. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J. Immunol. 180:6237-6245.
58. Rödel J, Assefa S, Prochnau D, Woytas M, Hartmann M, Groh A, Straube E. 2001. Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells. FEMS Immunol. Med. Microbiol. 32:9-15.
59. Nagarajan UM, Ojcius DM, Stahl L, Rank RG, Darville T. 2005. Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. J. Immunol. 175:450-460.
60. Ishihara T, Aga M, Hino K, Ushio C, Taniguchi M, Iwaki K, Ikeda M, Kurimoto M. 2005. Inhibition of Chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferongamma and tumor necrosis factor-alpha. Biomed. Res. 26:179-185.
61. Derbigny WA, Kerr MS, Johnson RM. 2005. Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J. Immunol. 175:6065-6075.
62. Derbigny WA, Shobe LR, Kamran JC, Toomey KS, Ofner S. 2012. Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells. Infect. Immun. 80:254-265.
63. Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, Zaver SA, Schenk M, Zeng S, Zhong W, Liu ZJ, Modlin RL, Liu YJ, Cheng G. 2012. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13:1155-1161.
64. Abdullah Z, Schlee M, Roth S, Mraheil MA, Barchet W, Böttcher J, Hain T, Geiger S, Hayakawa Y, Fritz JH, Civril F, Hopfner KP, Kurts C, Ruland J, Hartmann G, Chakraborty T, Knolle PA. 2012. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J. 31:4153-4164.
65. Heinzen RA, Hackstadt T. 1997. The Chlamydia trachomatis parasito-phorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect. Immun. 65:1088-1094.
66. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. 2008. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc. Natl. Acad. Sci. U. S. A. 105:9379-9384.
67. Kumar Y, Cocchiaro J, Valdivia RH. 2006. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr. Biol. 16:1646-1651.
68. Elwell CA, Jiang S, Kim JH, Lee A, Wittmann T, Hanada K, Melancon P, Engel JN. 2011. Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development. PLoS Pathog. 7:e1002198. http://dx.doi.10.1371/journal.ppat.1002198.
69. Derré I, Swiss R, Agaisse H. 2011. The lipid transfer protein CERT interacts with the chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 7:e1002092. http://dx.doi.10.1371/journal.ppat.1002092.
70. Dumoux M, Clare DK, Saibil HR, Hayward RD. 2012. Chlamydiae assemble a pathogen synapse to hijack the host endoplasmic reticulum. Traffic 13:1612-1627.
71. Tanaka Y, Chen ZJ. 2012. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5:ra20. http://dx.doi.10.1126/scisignal.2002521.
72. Srivastava D, Waters CM. 2012. A tangled web: regulatory connections between quorum sensing and cyclic di-GMP. J. Bacteriol. 194:4485-4493.
73. Rao F, See RY, Zhang D, Toh DC, Ji Q, Liang ZX. 2010. YybT is a signaling protein that contains a cyclic dinucleotide phosphodiesterase domain and a GGDEF domain with ATPase activity. J. Biol. Chem. 285: 473-482.
74. Massie JP, Reynolds EL, Koestler BJ, Cong JP, Agostoni M, Waters CM. 2012. Quantification of high-specificity cyclic diguanylate signaling. Proc. Natl. Acad. Sci. U. S. A. 109:12746-12751.